NFAT5 and osteoporosis: In summary, this study suggests that KCNQ1OT1, as a sponge for miR-128-3p, inhibits the osteoclast differentiation of RAW 264.7 cells through NFAT5 activation (Figure 7), which might provide a promising therapeutic approach to the prevention and treatment of osteoporosis.